This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Antibiotic Resistance 2013: The Antibiotics Development Pipeline And Strategies To Combat Antibiotic Resistance

Table 3.5 Approved/marketed cephalosporins, which exert their bactericidal effects through the inhibition of cell wall synthesis (Source: Biopharm Reports, 2013).

Table 3.6 Approved/marketed 1st, 2nd, 3rd and 4th generation cephalosporins, which exert their bactericidal effects through the inhibition of cell wall synthesis (Source: Biopharm Reports, 2013).

Table 3.7 Approved/marketed carbapenems and one monobactam (Aztreonam), which exert their bactericidal effects through the inhibition of cell wall synthesis (Source: Biopharm Reports, 2013).

Table 3.8 Approved/marketed aminoglycosides, which exert their bactericidal effects through the inhibition of protein synthesis (Source: Biopharm Reports, 2013).

Table 3.9 Approved/marketed tetracyclines, which exert their bactericidal effects through the inhibition of protein synthesis (Source: Biopharm Reports, 2013).

Table 3.10 Approved/marketed quinolones and fluoroquinolones, which exert their bactericidal effects through the inhibition of DNA transcription (Source: Biopharm Reports, 2013).

Table 3.11 Approved/marketed macrolides, which exert their bactericidal effects through the inhibition of protein synthesis (Source: Biopharm Reports, 2013).

Table 3.12 Approved/marketed combination antibiotics, which exert their bactericidal

effects through the combined effects of both molecules (Source: Biopharm Reports, 2013).

Table 3.13 Approved/marketed folate antagonists, which exert their bactericidal

effects through the inhibition of the folate cycle (Source: Biopharm Reports, 2013).

Table 3.14 Approved/marketed mycobacterials, which exert their mycocidal effects through multiple mechanisms (Source: Biopharm Reports, 2013).

Table 3.15 Approved/marketed glycopeptides, which exert their bactericidal effects through the inhibition cell wall synthesis (Source: Biopharm Reports, 2013).

Table 3.16 Other approved/marketed antibiotics, which exert their bactericidal effects through multiple mechanisms (Source: Biopharm Reports, 2013).

Table 3.17 Other approved/marketed antibiotics, which exert their bactericidal effects through multiple mechanisms (Source: Biopharm Reports, 2013).

Table 4.1 Companies with pipeline bacterial ICorps = blue (Source: Biopharm Reports, 2013)

Table 4.2 Antibiotics in Phase 3 Development (Source: Biopharm Reports, 2013)

Table 4.3 Antibiotics in Phase 2 Development (Source: Biopharm Reports, 2013)

Table 4.4 Antibiotics in Phase 1 Development (Source: Biopharm Reports, 2013)

5 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs